BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,524 | -74.0% | 21,551 | -31.5% | 0.00% | – |
Q2 2023 | $209,497 | -37.5% | 31,456 | +75.1% | 0.00% | – |
Q1 2023 | $335,190 | +11.6% | 17,963 | +28.5% | 0.00% | – |
Q4 2022 | $300,290 | +79.8% | 13,980 | -1.1% | 0.00% | – |
Q3 2022 | $167,000 | -9.7% | 14,130 | +0.6% | 0.00% | – |
Q2 2022 | $185,000 | -38.9% | 14,041 | -3.2% | 0.00% | – |
Q1 2022 | $303,000 | +9.8% | 14,500 | +6.8% | 0.00% | – |
Q4 2021 | $276,000 | -32.7% | 13,574 | +0.5% | 0.00% | – |
Q3 2021 | $410,000 | +13.6% | 13,511 | +8.6% | 0.00% | – |
Q2 2021 | $361,000 | -32.8% | 12,443 | -0.1% | 0.00% | – |
Q1 2021 | $537,000 | -76.2% | 12,450 | -74.5% | 0.00% | -100.0% |
Q4 2020 | $2,254,000 | -12.4% | 48,751 | -17.9% | 0.00% | -50.0% |
Q3 2020 | $2,574,000 | +1.2% | 59,380 | +23.8% | 0.00% | 0.0% |
Q2 2020 | $2,543,000 | – | 47,982 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $7,040,000 | 3.41% |
Ikarian Capital, LLC | 693,716 | $15,505,000 | 1.17% |
EAM Global Investors LLC | 71,838 | $1,606,000 | 0.94% |
Avidity Partners Management LP | 211,000 | $4,716,000 | 0.65% |
MOODY ALDRICH PARTNERS LLC | 79,642 | $1,780,000 | 0.54% |
Knoll Capital Management, LLC | 20,000 | $447,000 | 0.42% |
EAM Investors, LLC | 55,775 | $1,247,000 | 0.39% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 299,932 | $6,703,000 | 0.22% |
Coastal Bridge Advisors, LLC | 25,014 | $559,000 | 0.20% |
Ikarian Capital, LLC | 103,300 | $2,309,000 | 0.17% |